CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
omafilcon A control lens +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04709237
NCT04709237N/ACompleted

Evaluation of The Clinical Acceptance of Soft Contact Lenses for Myopia Control

CooperVision, Inc.·interventional·Posted Jan 14, 2021·Updated Aug 27, 2024

In Brief

A clinical study evaluating omafilcon A control lens, omafilcon A test lens 1, and 1 other intervention for Myopia. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The main objective of the study was to evaluate the clinical acceptance of soft contact lenses for Myopia control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 14, 2021
Enrollment StartDec 14, 2019
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.5 years ago

Interventions

omafilcon A control lensdevice

Participants were randomized to wear omafilcon A control soft contact lens for 10 days.

omafilcon A test lens 1device

Participants were randomized to wear omafilcon A test soft contact lens 1 for 10 days.

omafilcon A test lens 2device

Participants were randomized to wear omafilcon A test soft contact lens 2 for 10 days.